Sarah-MorganProfessor of Medicine
Medical Director, Osteoporosis Clinic, Center for Metabolic Bone Disease


830 Faculty Office Tower
510 20th Street South
Birmingham, AL 35294-3408

Telephone:(205) 934-3235
Fax:(205) 934-4602



BS (Nutrition and Dietetics), Iowa State University, 1977
BS (Nutrition and Related Sciences), Iowa State University, 1977
MD, The University of Iowa, 1981
Internship and Residence (Internal Medicine), University of Iowa Hospitals and Clinics, Iowa City, 1981-1984
Fellowship (Clinical Nutrition), The University of Alabama at Birmingham, 1984-1986
MS (Nutrition), The University of Alabama at Birmingham, 1987



C.E. Butterworth Award, UAB - 1986
Outstanding Young Alumna, Iowa State University, 1991
Outstanding Young Alumna, UAB Department of Nutrition Sciences, School of Health Related Professions
Distinguished Achievement Citation, Iowa State University, 1999
Outstanding UAB Woman Faculty Member, 2001
Distinguished Alumlnus Award for Achievement, University of Iowa 2007
UAB School of Health Professions - Member of "Fab 40" - 2009
Sam Brown Bridge Builder Award, UAB, 2010
President, International Society for Clinical Densitometry, 2011-2012


Research Description

Dr. Morgan's research program has been focused on methotrexate and folic acid metabolism in patients with rheumatoid arthritis.  Her work with Dr. Joseph E Baggott and members of the Division of Clinical Immunology and Rheumatology (Drs. Graciela Alarcon, Dr. William Koopman, Dr. S Louis Bridges, and Dr. Laura Hughes) have established the folic acid supplementation during low dose methotrexate therapy for rheumatoid arthritis lowers toxicity without affecting efficacy.  Drs Morgan and Baggott have also studied purine metabolism and methotrexate therapy in rat adjuvant arthritis and participate in trials related to methotrexate pharmacogenetics.  Dr. Morgan and Dr. Baggott have also investigated the effects of a medical food on osteoarthritis.

As the Medical Director of the UAB Osteoporosis Prevention and Treatment Clinic, Dr. Morgan has an interest in bone densitometry and clinical trials related to osteoporosis.



Click here for a more complete list of publications. Below are selected papers.

Morgan SL, Baggott JE, Altz-Smith M.  1987. Folate status of rheumatoid arthritis patients on long-term, low-dose methotrexate therapy.  Arthritis Rheum; 30: 1348-56. PMID:3124860

Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcón GS.  1990. The effect of folic acid supplementation on the toxicity of low-dose methotrexate treatment of rheumatoid arthritis.  Arthritis Rheum 33:  9-18. PMID: 2405864

Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarcón GS. 1994. Supplementation with folic acid during methotrexate therapy of rheumatoid arthritis: results from a double-blind, placebo-controlled trial.  Ann Intern Med 121: 833-841. PMID:7978695

Morgan SL, Baggott JE, Lee JY, Alarcón GS.  1998. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention.  J Rheumatol 25: 441-446. PMID:9517760

Morgan SL, Baggott JE, Alarcon GS, Bernreuter W, Arani R.  2001. Separation of inflammation and destructive response - MTX affects inflammation and tissue destruction different in the rat AA model, J Rheumatol 28: 1476-81. PMID:11469449

Goodson T, Morgan SL, Carlee JR, Baggott JE.  2003. The energy cost of adjuvant-induced arthritis in rats.  Arthritis Rheum 48: 2979-2982. PMID:14558105

Morgan SL, Abercrombie W, Lee JY.  2003. Need for precision studies at individual institutions and assessment of size of regions of interest on serial DXA scans. J Clin Densitometry, 6: 97-101. PMID: 12794231

Morgan SL, Chen DS, Carlee J, Baggott JE.  2004. Effect of methotrexate on bone mineral density and body composition in rat adjuvant arthritis.  J Rheumatol 31a;1693-7. PMID:15338486

Morgan SL, Oster RA, Lee JY, Alarcón GS, Baggott JE.  2004. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis.  Arthritis Rheum 50:3104-3111. PMID:15476202

Baggott JE, Bridges SL, Morgan SL.  2005. Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis.  Arthritis Rheum 52: 356-358. PMID:15641087

Morgan SL, Baggott JE.  2006. Medical Foods: Products for the Management of Chronic Diseases.  Nutrition Reviews 64: 495-501. PMID:17131945

Baggott JE, Morgan SL.  2007. Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism.  Euro J Pharm Sci 31: 95-101. PMID:17408934

Morgan SL, Lopez-Ben R, Nunnally N, Burroughs L, Fineberg N, Tubbs SH, Yester MV.  2008. "Black hole artifacts": a New Potential Pitfall for DXA Accuracy, J Clin Densitometry 11:266-275. PMID:18291695

Morgan SL, Lopez-Ben R, Nunnally N, Burroughs L, Fineberg N, Tubbs SH, Yester MV.  2008. The effect of common artifacts lateral to the spine on bone mineral density in the lumbar spine.  J Clin Densitometry,11:243-249. PMID:18291694

Mann ML, Thornley-Brown D, Campbell R, Bell E, Feng R, Morgan SL.  2008. The effect of peritoneal dialysate on DXA bone densitometry results in patients with end-stage renal disease. J Clin Densitom 11:532-6. PMID:18809346

Morgan SL, Baggott JE, Moreland L, Desmond R, Kendrach AC.  2009. The safety of flavocoxid, a medical food, in the dietary management of knee osteoarthritis.  J Medicinal Food 12: 1143-1148. PMID:19857081

Baggott JE, Morgan SL.  2009. Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis alters drug efficacy and retention and is reduced by folic acid supplementation.  Arthritis Rheum 60:2257-2261. PMID:19644884

Morgan SL.  2009. Nutrition and bone: it is more than calcium and vitamin D.  Women's Health 5: 727-737. PMID:19863475

Danila MI, Hughes LB, Brown EE, Morgan SL, Baggott JE, Arnett DK, Bridges SL Jr  2010. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?  Curr Rheumatol Rep 12: 342-7. PMID:20665136

Binkley N, Krueger DC, Morgan S, Wiebe D.  2010. Current status of clinical 25-hydroxyvitamin D measurement: An assessment of between-laboratory agreement.  Clin Chim Acata 13: 283-91. PMID: 20713030

Morgan SL, Baggott JE.  2010. Folate supplementation during methotrexate therapy for rheumatoid arthritis.  Clin Exp Rheumatol 28 (Suppl 61): S102-109. PMID:21044441

Pitt MJ, Morgan SL, Lopez-Ben R, Stellman RE, Nunnally N, Burroughs L, Fineberg N.  Association of the presence of bone bars on radiographs and low bone mineral density.  Skeletal Radiol, 40:905-911. PMID:21243354

Baggott JE, Gorman GS, Morgan SL. 2011. Phenotypes and circadian rhythm in utilization of formate in purine nucleotide biosynthesis de novo in adult humans. Life Sci. 88(15-16):688-92. PMID: 21324323

Kiebzak GM, Morgan SL.  2011. Long-term vs. short-term precision of dual-energy x-ray absorptiometry scans and the impact of interpreting change in bone mineral density at follow-up.  J Clinical Densitometry  14: 108-115.

Kiebzak GM, Morgan SL, Peace F. 2012. Which to use to evaluate change in BMD at follow-up: RMS-SD or RMS-%CV? J Clin Densitom. 15(1):26-31. PMID:22154429

Lewiecki EM, Bilezikian JP, Jankowski LG, McCloskey EV, Miller PD, Morgan SL, Orwoll ES, Potts JT Jr. 2012. Proceedings of the 2011 Santa Fe Bone symposium. J Clin Densitom. 15(1):1-20. PMID:22284629

Halilova KI, Brown EE, Morgan SL, Bridges SL Jr, Hwang MH, Arnett DK, Danila MI. 2012. Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol. 2012;2012:978396. PMID:22844292 Free PMC Article

Reddy MS, Morgan SL. 2013. Decreased bone mineral density and periodontal management. Periodontol 2000. 61(1):195-218. PMID:23240950

Richter HE, Morgan SL, Gleason JL, Szychowski JM, Goode PS, Burgio KL. 2013. Pelvic floor symptoms and bone mineral density in women undergoing osteoporosis evaluation. Int Urogynecol J. 24(10):1663-9. PMID:23389642

Prater GL, Jankowski LC, Peace F, Nunnally N, Burroughs L Morgan SL. 2014. The Effect of extending femur scan length on bone mineral density results on the Hologic Discovery-W scanner. J Clin Densitom 17: 518-21. PMID: 24176430

Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi J, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J. 2015. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30: 3-23. PMID: 25414052

Meyer I, McArthur TA, Tang Y, McKinney JL, Morgan SL, Richter HE. 2016. Pelvic floor symptoms and spinal curvature in women. Female Pelvic Reconstru Surg 22: 219-23. PMID: 27054800 PMCID: PMC4919232

Lewiecki EM, Binkley N, Morgan SL, Shuhart CR, Camargos BM, Carey JJ, Gordon CM, Jankowski LG, Lee JK, Leslie WD. 2016. Best practices for dual-energy x-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 10: 127-40. PMID: 27020004

Beyl RN Jr, Hughes L, Morgan S. Update on importance of diet in gout. Am J Med 2016, July 22 [Epub ahead of print}.

Morgan SL, Prater GL. 2017 Quality in dual-energy X-ray absorptiometry scans. Bone. 2017 Jan 31. [Epub ahead of print] PMID: 28159711



SOM Epilogue Menu